Antipodean Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSG
The Stars Group Inc.
TSG
|
+$6.91M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$4.36M |
| 3 |
Charter Communications
CHTR
|
+$3.76M |
| 4 |
PPLI
People Inc
PPLI
|
+$1.77M |
| 5 |
Amazon
AMZN
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$16.6M |
| 2 |
Autodesk
ADSK
|
+$8.81M |
| 3 |
Alibaba
BABA
|
+$8.47M |
| 4 |
Agilent Technologies
A
|
+$7.1M |
| 5 |
Domino's
DPZ
|
+$3.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.62% |
| 2 | Communication Services | 22.52% |
| 3 | Technology | 16.11% |
| 4 | Financials | 13.47% |
| 5 | Healthcare | 10.54% |
Similar funds
Antipodean Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Antipodean Advisors held 18 positions worth $90.5M, down 27% from $123M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Antipodean Advisors withdrew a net $38.1M in Q1 2018, closing 5 positions and reducing 7 holdings. Its most notable exit was Agilent Technologies, an estimated $7.1M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 26% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Antipodean Advisors opened a new position in The Stars Group Inc. worth $7.28M.
- Antipodean Advisors's largest Q1 2018 buy was The Stars Group Inc.: 264,000 shares worth $7.28M.
- Antipodean Advisors added most to Medicines Co in Q1 2018, an estimated $4.36M increase.
- Antipodean Advisors's biggest Q1 2018 reduction was Exact Sciences, cutting an estimated $16.6M.
- Antipodean Advisors fully exited Agilent Technologies in Q1 2018, selling an estimated $7.1M.
- Antipodean Advisors's ten largest holdings make up 96% of its $90.5M portfolio in Q1 2018.
- Antipodean Advisors opened 2 new positions and closed 5 in Q1 2018.
- Antipodean Advisors's portfolio value fell 27% quarter-over-quarter to $90.5M.
Based on Antipodean Advisors's 13F filing for Q1 2018, filed 15 May 2018.